Tradestie Institutional Equity Comparison Engine

VSTM vs RGNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VSTM Overall Edge

VSTM Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Verastem, Inc. (VSTM) driven by superior Momentum & Technical, Options & Structure while RGNX counters with relative strength in Valuation, Growth & Margin. Fundamentally, VSTM trades at N/M Forward P/E with -193.7% operating margin (+113.6% YoY revenue) versus RGNX at N/M Forward P/E and -120.4% operating margin (-69.2% YoY). In options structure, VSTM sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro) against RGNX sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner RGNX
VSTM N/M vs RGNX N/M Fwd P/E
Growth & Margin Winner RGNX
Op Margin -193.7% vs -120.4% ยท YoY +113.6% vs -69.2%
Momentum & Technical Winner VSTM
1Y -2.6% vs -36.0% ยท 52W Pos 60% vs 19%
Options & Structure Winner VSTM
CONSOLIDATION (10th %ile IV) vs BREAKDOWN (52nd %ile IV)
VSTM NASDAQ
Verastem, Inc.
Pharmaceutical Preparations
$7.89
-3.48% 1D
Market Cap $1.1B
1M Return -8.73%
1Y Return -2.65%
Forward P/E N/M
Unified AI Score
56.9 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 64.0 Mom 70.0
RGNX NASDAQ
REGENXBIO Inc.
Biological Products, (No Disgnostic Substances)
$7.45
-2.49% 1D
Market Cap $500.9M
1M Return +7.58%
1Y Return -36.0%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 36.0 Fund 44.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VSTM -2.65% RGNX -36.0% Spread: +33.35 pp (VSTM Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VSTM Revenue RGNX Revenue VSTM Op. Margin RGNX Op. Margin Margin Edge
FY2018 $30M $220M -354.8% 40.3% RGNX
FY2019 $20M $40M -758.1% -422.9% RGNX
FY2020 $90M $150M -55.8% -77.1% VSTM
FY2021 $0M $470M -2991.2% 34.0% RGNX
FY2022 $0M $110M -2809.6% -233.2% RGNX
FY2023 N/A $90M N/A -297.1% RGNX
FY2024 $10M $80M -1149.6% -280.0% RGNX
FY2025 $30M $170M -550.3% -94.6% RGNX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VSTM (5) vs RGNX (3)
Institutional Metric VSTM RGNX Criterion Row Winner
Market Capitalization Scale $1.1B $500.9M Larger Scale VSTM
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +113.6% -69.2% Higher Growth VSTM
Operating Margin (TTM) Profitability -193.7% -120.4% Higher Margin RGNX
Net Profit Margin Profitability -178.4% -113.9% Higher Margin RGNX
Return on Equity (ROE) Capital Efficiency -471.2% -113.2% Higher ROE RGNX
52-Week Range Position Momentum 60% ($3โ€“$11) 19% ($5โ€“$16) Stronger Trend VSTM
Beta / 30D Volatility Risk Regime 1.11ฮฒ ยท 72% Vol 1.82ฮฒ ยท 76% Vol Lower Realized Risk VSTM
Unified Institutional Score Composite Signal 56.9 / 100 (HOLD) 45.3 / 100 (HOLD) Higher Composite VSTM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VSTM vs RGNX Buy Guide
VSTM CONSOLIDATION
50d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live VSTM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RGNX BREAKDOWN
91d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 52nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live RGNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VSTM nor RGNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.